Disparities in hemodynamic resuscitation of the obese critically ill septic shock patient

Journal of Critical Care

Volumn 37, Issue , 2017, Pages 219-223

  Adams, Chere ^a   Tucker, Calvin ^a   Allen, Bryan ^a   McRae, Andrew ^b   Balazh, Julia ^b   Horst, Spencer ^b   Johnson, Donald ^b   Ferreira, Jason ^b  

^a St Vincent's Medical Center Jacksonville   (United States)

^b UNIVERSITY OF FLORIDA HEALTH JACKSONVILLE   (United States)

Author keywords

Catecholamine; Hemodynamics; Obesity; Shock; Vasoactive agents

Indexed keywords

CATECHOLAMINE; VASOCONSTRICTOR AGENT;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DEATH; FEMALE; GENDER; HEALTH CARE DISPARITY; HEMODYNAMIC RESUSCITATION; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTICENTER STUDY; OBESITY; OUTCOME ASSESSMENT; PATIENT CARE; PRACTICE GUIDELINE; RESUSCITATION; SEPTIC SHOCK; SHOCK; TIME TO TREATMENT; TREATMENT INDICATION; CAUSE OF DEATH; COMORBIDITY; CRITICAL ILLNESS; DOSE CALCULATION; FLUID THERAPY; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; SHOCK, SEPTIC; TIME FACTOR;

AGED; ARTERIAL PRESSURE; BODY WEIGHT; CATECHOLAMINES; CAUSE OF DEATH; COMORBIDITY; CRITICAL ILLNESS; DRUG DOSAGE CALCULATIONS; FEMALE; FLUID THERAPY; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MORTALITY; OBESITY; RESUSCITATION; RETROSPECTIVE STUDIES; SHOCK; SHOCK, SEPTIC; TIME FACTORS; VASOCONSTRICTOR AGENTS;

EID: 85006096653     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2016.10.004     Document Type: Article

References (36)

1. [1] Dellinger, R.P., Levy, M.M., Rhodes, A., Annane, D., Gerlach, H., Opal, S.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39 (2013), 165–228.
2. [2] Mayr, F.B., Yende, S., Angus, D.C., Epidemiology of severe sepsis. Virulence 5 (2014), 4–11.
3. [3] Beck, V., Chateau, D., Bryson, G.L., Pisipati, A., Zanotti, S., Parrillo, J.E., et al. Timing of vasopressor initiation and mortality in septic shock: a cohort study. Crit Care, 18, 2014, R97.
4. [4] Sakr, Y., Alhussami, I., Nanchal, R., Wunderink, R.G., Pellis, T., Wittebole, X., et al. Being overweight is associated with greater survival in ICU patients: results from the intensive care over nations audit. Crit Care Med 43 (2015), 2623–2632.
5. [5] Renehan, A.G., Buchan, I.E., The impact of excess body weight at the hospital frontline. BMC Med 12 (2014), 64–7015 [12-64].
6. [6] Jensen, M.D., Ryan, D.H., Apovian, C.M., Ard, J.D., Comuzzie, A.G., Donato, K.A., et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol 63 (2014), 2985–3023.
7. [7] Finkelstein, E.A., Trogdon, J.G., Cohen, J.W., Dietz, W., Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood) 28 (2009), w822–w831.
8. [8] Bercault, N., Boulain, T., Kuteifan, K., Wolf, M., Runge, I., Fleury, J.C., Obesity-related excess mortality rate in an adult intensive care unit: a risk-adjusted matched cohort study. Crit Care Med 32 (2004), 998–1003.
9. [9] Nasraway, S.A. Jr., Albert, M., Donnelly, A.M., Ruthazer, R., Shikora, S.A., Saltzman, E., Morbid obesity is an independent determinant of death among surgical critically ill patients. Crit Care Med 34 (2006), 964–970 [quiz 971].
10. [10] Wacharasint, P., Boyd, J.H., Russell, J.A., Walley, K.R., One size does not fit all in severe infection: obesity alters outcome, susceptibility, treatment, and inflammatory response. Crit Care, 17, 2013, R122.
11. [11] Hanley, M.J., Abernethy, D.R., Greenblatt, D.J., Effect of obesity on the pharmacokinetics of drugs in humans. Clin Pharmacokinet 49 (2010), 71–87.
12. [12] Erstad, B.L., Dosing of medications in morbidly obese patients in the intensive care unit setting. Intensive Care Med 30 (2004), 18–32.
13. [13] Arabi, Y.M., Dara, S.I., Tamim, H.M., Rishu, A.H., Bouchama, A., Khedr, M.K., et al. Clinical characteristics, sepsis interventions and outcomes in the obese patients with septic shock: an international multicenter cohort study. Crit Care, 17, 2013, R72.
14. [14] Kane-Gill, S.L., Wytiaz, N.P., Thompson, L.M., Muzykovsky, K., Buckley, M.S., Cohen, H., et al. A real-world, multicenter assessment of drugs requiring weight-based calculations in overweight, adult critically ill patients. ScientificWorldJournal, 909135, 2013, 2013.
15. [15] Beloncle, F., Lerolle, N., Radermacher, P., Asfar, P., Target blood pressure in sepsis: between a rock and a hard place. Crit Care, 17, 2013, 126.
16. [16] Bangash, M.N., Kong, M.L., Pearse, R.M., Use of inotropes and vasopressor agents in critically ill patients. Br J Pharmacol 165 (2012), 2015–2033.
17. [17] Badin, J., Boulain, T., Ehrmann, S., Skarzynski, M., Bretagnol, A., Buret, J., et al. Relation between mean arterial pressure and renal function in the early phase of shock: a prospective, explorative cohort study. Crit Care, 15, 2011, R135.
18. [18] Annane, D., Vignon, P., Renault, A., Bollaert, P.E., Charpentier, C., Martin, C., et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 370 (2007), 676–684.
19. [19] Genga, K., Russell, J.A., Early liberal fluids for sepsis patients are harmful. Crit Care Med, 2016.
20. [20] Marik, P.E., Fluid responsiveness and the six guiding principles of fluid resuscitation. Crit Care Med, 2015.
21. [21] Hilton, A.K., Bellomo, R., A critique of fluid bolus resuscitation in severe sepsis. Crit Care, 16, 2012, 302.
22. [22] Boyd, J.H., Forbes, J., Nakada, T.A., Walley, K.R., Russell, J.A., Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 39 (2011), 259–265.
23. [23] Maitland, K., Kiguli, S., Opoka, R.O., Engoru, C., Olupot-Olupot, P., Akech, S.O., et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med 364 (2011), 2483–2495.
24. [24] Myburgh, J., Finfer, S., Causes of death after fluid bolus resuscitation: new insights from FEAST. BMC Med 11 (2013), 67–7015 [11-67].
25. [25] Russell, J.A., Walley, K.R., Singer, J., Gordon, A.C., Hebert, P.C., Cooper, D.J., et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358 (2008), 877–887.
26. [26] Sprung, C.L., Annane, D., Keh, D., Moreno, R., Singer, M., Freivogel, K., et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 358 (2008), 111–124.
27. [27] Martino, J.L., Stapleton, R.D., Wang, M., Day, A.G., Cahill, N.E., Dixon, A.E., et al. Extreme obesity and outcomes in critically ill patients. Chest 140 (2011), 1198–1206.
28. [28] Trivedi, V., Bavishi, C., Jean, R., Impact of obesity on sepsis mortality: a systematic review. J Crit Care 30 (2015), 518–524.
29. [29] Bajwa, S.J., Sehgal, V., Bajwa, S.K., Clinical and critical care concerns in severely ill obese patient. Indian J Endocrinol Metab 16 (2012), 740–748.
30. [30] Kolyva, A.S., Zolota, V., Mpatsoulis, D., Skroubis, G., Solomou, E.E., Habeos, I.G., et al. The role of obesity in the immune response during sepsis. Nutr Diabetes, 4, 2014, e137.
31. [31] Hutagalung, R., Marques, J., Kobylka, K., Zeidan, M., Kabisch, B., Brunkhorst, F., et al. The obesity paradox in surgical intensive care unit patients. Intensive Care Med 37 (2011), 1793–1799.
32. [32] Abboud, I., Lerolle, N., Urien, S., Tadie, J.M., Leviel, F., Fagon, J.Y., et al. Pharmacokinetics of epinephrine in patients with septic shock: modelization and interaction with endogenous neurohormonal status. Crit Care, 13, 2009, R120.
33. [33] Beloeil, H., Mazoit, J.X., Benhamou, D., Duranteau, J., Norepinephrine kinetics and dynamics in septic shock and trauma patients. Br J Anaesth 95 (2005), 782–788.
34. [34] Klem, C., Dasta, J.F., Reilley, T.E., Flancbaum, L.J., Variability in dobutamine pharmacokinetics in unstable critically ill surgical patients. Crit Care Med 22 (1994), 1926–1932.
35. [35] MacGregor, D.A., Smith, T.E., Prielipp, R.C., Butterworth, J.F., James, R.L., Scuderi, P.E., Pharmacokinetics of dopamine in healthy male subjects. Anesthesiology 92 (2000), 338–346.
36. [36] Johnston, A.J., Steiner, L.A., O'Connell, M., Chatfield, D.A., Gupta, A.K., Menon, D.K., Pharmacokinetics and pharmacodynamics of dopamine and norepinephrine in critically ill head-injured patients. Intensive Care Med 30 (2004), 45–50.